Literature DB >> 22075774

Synovial lesions in experimental canine Lyme borreliosis.

L Susta1, E W Uhl, D A Grosenbaugh, P M Krimer.   

Abstract

Borrelia burgdorferi is the causative agent of Lyme disease, which is mainly characterized by lameness in dogs. More than 95% of naturally infected dogs are asymptomatic or subclinical; however, in experimental studies, histologic synovial lesions are consistently observed in asymptomatic dogs inoculated with B. burdgorferi. This study investigates the ability of a synovial histopathologic scoring system, clinicopathologic data, and polymerase chain reaction (PCR) testing to differentiate between B. burgdorferi-infected and uninfected dogs. Eighteen 18-week-old beagles were subject to challenge with B. burgdorferi-infected wild-caught ticks (Ixodes scapularis), and 4 uninfected dogs served as controls. Infection was confirmed by serology (ELISA) and PCR amplification of B. burgdorferi-specific DNA of skin biopsies taken at the tick attachment site. A synovial scoring system from human medicine was adapted and implemented on postmortem synovial samples to discriminate infected and noninfected animals. Application of this system to elbows and stifles with a cumulative joint score cutoff  > 4 showed a sensitivity of 88.2% and a specificity of 100%, with a positive likelihood ratio of infinity and a negative likelihood ratio of 0.12. Complete blood count, serum biochemistry, urinalysis, urine protein:creatinine, urine PCR, synovial and lymph node cytology, and synovial PCR were evaluated but were not reliable indicators of clinical disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075774     DOI: 10.1177/0300985811424754

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  5 in total

1.  Tick-borne Diseases (Borreliosis, Anaplasmosis, Babesiosis) in German and Austrian Dogs: Status quo and Review of Distribution, Transmission, Clinical Findings, Diagnostics and Prophylaxis.

Authors:  Nikola Pantchev; Silvia Pluta; Elke Huisinga; Stephanie Nather; Miriam Scheufelen; Majda Globokar Vrhovec; Andrea Schweinitz; Herwig Hampel; Reinhard K Straubinger
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

2.  Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme Disease.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Terri L Wasmoen; Dean A Jobe; Steven D Lovrich
Journal:  Clin Vaccine Immunol       Date:  2015-05-13

3.  Lyme disease risk in dogs in New Brunswick.

Authors:  Natalie K Bjurman; Gina Bradet; Vett K Lloyd
Journal:  Can Vet J       Date:  2016-09       Impact factor: 1.008

4.  Comparison of effectiveness of cefovecin, doxycycline, and amoxicillin for the treatment of experimentally induced early Lyme borreliosis in dogs.

Authors:  Bettina Wagner; John Johnson; David Garcia-Tapia; Nicole Honsberger; Vickie King; Catherine Strietzel; John M Hardham; Thomas J Heinz; Richard T Marconi; Patrick F M Meeus
Journal:  BMC Vet Res       Date:  2015-07-25       Impact factor: 2.741

5.  ACVIM consensus update on Lyme borreliosis in dogs and cats.

Authors:  Meryl P Littman; Bernhard Gerber; Richard E Goldstein; Mary Anna Labato; Michael R Lappin; George E Moore
Journal:  J Vet Intern Med       Date:  2018-03-22       Impact factor: 3.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.